Water Vapor Ablation for Prostate Cancer: Long-Term Registry (VAPOR-LTR)
Vanquish® Water Vapor Ablation for PrOstate CanceR: Long-Term Registry
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Sydney Cartie
- Phone Number: 6122866855
- Email: scartie@francismedical.com
Study Contact Backup
- Name: Garrett Grenier
- Phone Number: 763-453-9404
- Email: ggrenier@francismedical.com
Study Locations
-
-
Louisiana
-
Bossier City, Louisiana, United States, 71111
- Recruiting
- WK Advanced Urology Specialists
-
Principal Investigator:
- Gerard Henry, MD
-
Contact:
- Ryan Wilkerson
- Phone Number: 318-212-7335
- Email: rwilkerson@wkhs.com
-
-
Minnesota
-
Woodbury, Minnesota, United States, 55125
- Recruiting
- Minnesota Urology
-
Principal Investigator:
- Aaron Milbank, MD
-
Contact:
- Melissa Robb
- Phone Number: 651-999-6800
- Email: mrobb@mnurology.com
-
-
Texas
-
San Antonio, Texas, United States, 78240
- Recruiting
- The Urology Place, Inc.
-
Principal Investigator:
- Naveen Kella, MD
-
Contact:
- Naveen Kella, MD
- Phone Number: 210-617-3670
- Email: nkella@theupi.com
-
Sub-Investigator:
- Savannah Eggerss, PA
-
-
Virginia
-
Virginia Beach, Virginia, United States, 23462
- Recruiting
- Urology of Virginia
-
Principal Investigator:
- Robert Given, MD
-
Contact:
- Robert Given, MD
- Phone Number: 757-452-3461
- Email: rgiven@urologyofva.net
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Candidate for Vanquish therapy per physician discretion or participant has completed a company-sponsored Vanquish therapy study.
- Participant is willing and able to provide written informed consent.
Exclusion Criteria:
- Contraindications per the Vanquish IFU
- Previously participated in VAPOR 2 study and is not planning to receive further Vanquish therapy.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Vanquish Procedure Patients
Patients that have completed or will complete a Vanquish therapy and plan to continue their routine clinical care.
|
The Francis Medical, Inc. Vanquish Water Vapor Ablation Device ("Vanquish" or "Vanquish System") is a transurethral thermal water vapor ablation device.
The Vanquish System is designed ablate prostate tissue, while minimizing side effects.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Efficacy Outcome
Time Frame: Through study completion, or up to 15 years.
|
Freedom from disease specific mortality.
|
Through study completion, or up to 15 years.
|
|
Primary Safety Outcome
Time Frame: Through study completion, or up to 15 years
|
Rate of complications classified as Clavien-Dindo grades III-V and attributable to the Vanquish procedure and/or device over time.
|
Through study completion, or up to 15 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 5600-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.